Waltzman Roger J. 4
4 · Indaptus Therapeutics, Inc. · Filed Jan 23, 2024
Insider Transaction Report
Form 4
Waltzman Roger J.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-22+75,000→ 75,000 totalExercise: $1.74Exp: 2034-01-22→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027.